Evidence map›Paper›PMID 42716689›Full record

ArticleBMJ open2026

Comparison of an ensemble machine learning model to a Cox regression model to predict colorectal cancer risk among people with HIV using retrospective nationwide cohort data in Sweden: a study protocol.

Josefin Nilsson, Yunyang Deng, Olof Elvstam, Isabela Killander-Möller, Jiayao Lei, Fredrik Mansson, Pontus Naucler, Jonas Nygren, Suzanne Ruhe-van der Werff, Philippe Wagner and 4 more

Abstract readComparative Study
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Josefin NilssonUnit of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden josefin.nilsson@ki.se.ORCID http://orcid.org/0009-0004-9306-2143
Yunyang DengDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Olof ElvstamDepartment of Translational Medicine, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0003-3799-9869
Isabela Killander-MöllerUnit of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.
Jiayao LeiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Fredrik ManssonDepartment of Clinical Sciences, Lund University, Infectious Diseases Research Unit, Malmo, Sweden.
Pontus NauclerDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Jonas NygrenDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
Suzanne Ruhe-van der WerffDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Philippe WagnerUppsala University, Uppsala, Sweden.
Aylin YilmazDepartment of Infectious Diseases, University of Gothenburg, Gothenburg,Sweden.
Johanna BrännströmUnit of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.
Magnus Boman *Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
Christina Carlander *Unit of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.ORCID http://orcid.org/0000-0001-9962-5964

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are currently no colorectal cancer (CRC) screening recommendations specifically outlined for people with HIV (PWH). Screening measures used for people without HIV (PWoH) have been previously discussed as sufficient for use among PWH, despite observations of higher CRC prevalence and CRC reportedly appearing at earlier ages among PWH in comparison to PWoH. Machine learning (ML) methods are regarded as robust approaches that may enhance predictive performance, particularly in the context of complex or high-dimensional data. This study aims to develop an ensemble ML model to predict CRC risk in PWH using comprehensive nationwide datasets. The model's predictive performance will be evaluated and compared with a baseline Cox proportional regression model. The better-performing method will be implemented to develop a CRC risk prediction model with the aim of personalising screening recommendations for PWH. METHODS AND ANALYSIS: The study population will include all PWH and PWoH born between 1940 and 2008, aged 18 or older and living in Sweden sometime between 1983 and 2024. The study population will be linked to six nationwide demographic and healthcare registers. Follow-up will continue until the first incident of CRC, emigration or death. The outcome of interest is CRC. PWH will be matched to negative controls 1:10. A Cox regression analysis will be completed first, and the results will be used as a baseline comparison to the ensemble ML results. A range of ML methods will be used to develop the ensemble model using stacking. ETHICS AND DISSEMINATION: This study has ethical approval from the Regional Ethical Committee in Sweden (Dnr: 2024-04185-02, 2024-06783-02, 2023-00191-01, 2022-02897-02, 2022-05624-01, 2018/11-31/2). Given that the study is retrospective and register-based, using only pseudonymised data, there are minimal physical, psychological or privacy risks to included individuals. All results will be presented at the population level with no possibility of identification. The results of this study will be submitted for publication in a peer-reviewed journal.

Indexed as

Colorectal NeoplasmsHIV InfectionsMachine LearningAdultEarly Detection of CancerEnsemble LearningFemaleHumansMalePredictive Learning ModelsProportional Hazards ModelsResearch DesignRetrospective StudiesRisk AssessmentRisk FactorsSwedenEpidemiologyEPIDEMIOLOGYHIV & AIDSMachine LearningMethodsSTATISTICS & RESEARCH METHODS

Identifiers

PMID42716689
PMCPMC13560964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.